Penhasi Adel

Dr. Penhasi Adel


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Carbohydrate Polymers
Verified
Journal Article
Closed access
PAPenhasi Adel
Penhasi Adel
VMVictor M. Meidan
Victor M. Meidan

3 January 2021 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
PAPenhasi Adel
Penhasi Adel
ARAlbert Reuveni
Albert Reuveni
IBIsrael Baluashvili
Israel Baluashvili

5 June 2020 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
PAPenhasi Adel
Penhasi Adel
AGAharon Gertler
Aharon Gertler
IBIsrael Baluashvili
Israel Baluashvili
OEOmar Elzinaty
Omar Elzinaty
DSDeborah E. Shalev
Deborah E. Shalev

15 September 2011 in Journal of Clinical Periodontology
Verified
Journal Article
Open access
PDF file
EMEli E. Machtei
Eli E. Machtei
IHIlan Hirsh
Ilan Hirsh
MFMaher Falah
Maher Falah
ESEyal Shoshani
Eyal Shoshani
AAAvi Avramoff
Avi Avramoff
PAPenhasi Adel
Penhasi Adel
Aim: The aim of the present randomized, double blind, parallel, 2‐arm clinical study was to examine the safety and efficacy of frequent applications of chlorhexidine chip (CHX) and flurbiprofen chip (FBP) in patients with chronic periodontitis.Methods: Sixty patients were randomized into CHX and FBP groups. Following OHI and scaling and root planing (SRP), baseline pocket depth (PD) measurements, gingival recession and bleeding on probing (BOP) were performed and repeated at week 4 and 8. The assigned chip was placed at weeks 0, 1, 2, 3, 5, 7.Results: Mean PD reduction in the CHX group was 2.08 mm (7.17 to 5.09, p < 0.0001). Mean PD reduction in the FBP group was 2.27 mm (6.72 to 4.45, p < 0.0001). Ninety‐seven percentage and 95% of these sites exhibited PD reduction ≥1 mm, while 38% and 34% of the sites exhibited PD ≥3 mm (FBP and CHX, respectively). Clinical attachment level gain (1.66 and 1.95 mm, respectively) was statistically significant (p < 0.0001). Baseline BOP dropped from 98% and 100% to 24% and 30% for the CHX and FBP groups, respectively (p < 0.0001).Conclusion: Frequent applications of CHX and FBP chips resulted in a significant improvement in the periodontal condition in these sites. Furthermore studies will be required to compare this new treatment regimen to SRP or SRP with single chip application.


19 May 2015 in Journal of Microencapsulation
Verified
Journal Article
Closed access
PDF file
PAPenhasi Adel
Penhasi Adel
In this study the application of thermo-sensitive sol-gel polymers in microencapsulation formulation of probiotic bacteria, Bifidobacterium animalis spp lactis, for powdered infant formula (PIF), which is reconstituted at 70 °C, has been assessed. A double-layered microcapsule containing hydroxypropyl methyl cellulose (HPMC) as an inner layer and an outer layer, as the smart coating layer, based on a combination of hydroxypropyl cellulose (HPC) and poloxamer was designed. Generally, this specific microencapsulation provided superior protection against the reconstitution temperature. A high molecular weight of HPC and a greater thickness of the smart coating layer resulted in a delayed release of the bacteria from the microcapsules especially in the PIF composition. However, this was compensated by a high stability of the bacteria at 70 °C. Both the surface texture and particle size distribution of microcapsules have been respectively characterised by scanning electron microscopy and particle size analysis.